2.0
Oct 30, 2011
Anonymous employee
Former employee
La Jolla, CA
Recommend
CEO approval
Business Outlook
Pros
In the Research realm, the resources and scientific capabilties were extraordinary. At the La Jolla site, the legacy of scientific integrity survived for a number of years beyond the acquisition by Pfizer but suffered in recent years.
Cons
The quality of the decision-making at the site governance and global leadership levels was abysmal. New strategies were paraded out with great fanfare and then abandoned within a year or two simply because a new guy took over at the top.